摘要 |
Disclosed are pharmaceutical compositions comprising the compound 2,2'-di(pyridin-4-yl)-1H,1'H-5,5'-bibenzo[d]imidazole, or a pharmaceutically acceptable N-oxide, salt, hydrate or solvate thereof, and a pharmaceutically acceptable excipient. The compositions find application in methods of treating infection with Clostridium difficile and in methods of treating Clostridium difficile -associated disease (CDAD). |
申请人 |
Summit Therapeutics plc |
发明人 |
Wilson, Francis, Xavier;Johnson, Peter, David;Vickers, Richard;Storer, Richard;Wynne, Graham, Michael;Roach, Alan, Geoffrey;De Moor, Olivier;Dorgan, Colin, Richard;Davis, Paul, James |